Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Eupnea Technologies
AddedFeb 18, 2024
UpdatedJun 18, 2026
Eupnea Technologies

Eupnea Technologies

Seed

Eupnea Technologies, founded in California, develops ventilators, licenses IP to India's Ayuron Medical for manufacturing.

HQ
South Pasadena, CA, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

Eupnea Technologies, founded in California, is dedicated to developing innovative ventilator technologies aimed at providing accessible and effective respiratory care. Their core mission is to enhance emergency medical response capabilities through advanced, portable ventilators. The company’s flagship product, the ayuVent1000, is a full-featured ventilator and monitor designed for portability and efficiency. Eupnea Technologies focuses on licensing its intellectual property and designs to Ayuron Medical Systems, an experienced medical device manufacturer based in India, to scale production and ensure global availability.

Notable affiliations include Ayuron Medical Systems, which brings over a decade of manufacturing expertise to the partnership. Eupnea Technologies has achieved significant milestones by successfully developing and testing the ayuVent1000 in California before transitioning to large-scale production in India. This collaboration has positioned Eupnea Technologies as a key player in the medical device industry, particularly in response to the increased demand for ventilators during the COVID-19 crisis. Their impact is marked by their commitment to improving emergency healthcare infrastructure globally.

Eupnea Technologies - Quick Facts

When was Eupnea Technologies founded?

Eupnea Technologies was founded in 2016.

Where is Eupnea Technologies' headquarters located?

Eupnea Technologies' headquarters is located in South Pasadena, CA, US.

When was Eupnea Technologies' last funding round?

Eupnea Technologies' most recent funding round was for $762.7k (USD) in August 2020.

How much has Eupnea Technologies raised to-date?

As of Aug 7, 2020, Eupnea Technologies has raised a total of $762.7k (USD).

How many employees does Eupnea Technologies have?

Eupnea Technologies has 5 employees as of Feb 5, 2024.

Eupnea Technologies - Classification

Ownership
  • Private
Geographic Exposure
  • Americas
Revenue
  • Licensing
  • Recurring
Main Product
  • Ventilators
Tags
  • Enterprise Government
  • Medicaltech Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified